Immediate and short-term cardiovascular effects of a new converting enzyme inhibitor (lisinopril) in essential hypertension
- 1 November 1988
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (13), 912-916
- https://doi.org/10.1016/0002-9149(88)90892-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Monotherapy of Hypertension with Angiotensin-Converting Enzyme InhibitorsAmerican Journal Of Medicine, 1984
- Antihypertensive efficacy of once daily MK-521, a new nonsulfhydryl angiotensin-converting enzyme inhibitorThe American Journal of Cardiology, 1984
- Enalapril maleate and a lysine analogue (MK‐521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.British Journal of Clinical Pharmacology, 1982
- Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.British Journal of Clinical Pharmacology, 1982
- Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.British Journal of Clinical Pharmacology, 1981
- Noninvasive assessment of load reduction in patients with asymptomatic aortic regurgitationAmerican Journal Of Medicine, 1980
- Systemic and regional hemodynamics in low, normal and high cardiac output borderline hypertension.Circulation, 1978
- Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamineLife Sciences, 1977
- Pathophysiologic assessment of hypertensive heart disease with echocardiographyThe American Journal of Cardiology, 1977
- Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergyThe American Journal of Cardiology, 1976